Longevity by Design
Do Longevity Supplements Really Work?
Why It Matters
Understanding which supplements truly work helps consumers avoid wasteful spending and potential health risks, especially as the anti‑aging market booms. This episode provides clinicians and the public with a science‑first framework for personalized nutrition and highlights the need for stricter quality controls to protect public health.
Key Takeaways
- •Multivitamins modestly boost cognition, blood pressure in at‑risk groups.
- •Healthy individuals gain little from routine multivitamin supplementation.
- •Supplement quality often poor; one‑third lack claimed ingredients.
- •Alpha‑ketoglutarate offers slight age‑reduction for active middle‑agers.
- •Spermidine and curcumin show limited benefits; diet preferred.
Pulse Analysis
The latest systematic review covering more than five million participants confirms that multivitamin‑mineral formulas can improve global cognition and modestly lower systolic blood pressure in people with poor diets, chemotherapy, or fracture recovery. However, the same data show no survival advantage, no benefit for COVID‑19 outcomes, and no consistent effect on other cognitive domains among healthy adults. Clinicians therefore advise a targeted strategy: measure serum vitamin and mineral levels, assess dietary quality, and prescribe supplements only when deficiencies or elevated risk are documented. This personalized nutrition model avoids unnecessary costs and potential overdosing.
Quality control emerges as a second major obstacle. Independent laboratory analyses of dozens of popular brands revealed that roughly one‑third contained 40‑60 % of the labeled dose, another third had barely detectable amounts, and the remaining third were essentially empty. Price, packaging color, or brand reputation did not predict accuracy. Consumers are advised to check for a clear expiry date—vitamins degrade over time like olive‑oil polyphenols—and to rely on manufacturers that publish batch‑specific assay results. Ultimately, stronger regulatory oversight, akin to FDA drug standards, is needed to protect buyers.
Beyond traditional vitamins, geroscience researchers are testing true geroprotectors. Alpha‑ketoglutarate, a Krebs‑cycle intermediate, has shown modest reductions in biological age—particularly in physically active adults aged 40‑60—while also dampening inflammation. Spermidine, abundant in Mediterranean diets, modestly improves memory in small trials, yet large‑scale RCTs are still lacking. Curcumin’s anti‑inflammatory and insulin‑sensitizing actions are supported by gram‑dose studies that lower CRP and HbA1c, but its poor bioavailability limits impact. The consensus remains: obtain these compounds primarily through a varied, plant‑rich diet and consider supplementation only after individualized assessment.
Episode Description
In this episode of Longevity by Design, host Dr. Gil Blander sits down with Dr. Andrea Maier, Professor in Medicine and Director of the NUS Academy for Healthy Longevity at the National University of Singapore’s School of Medicine. They explore what the evidence shows on supplements, and why “test, then treat” beats guesswork.
Andrea unpacks a review of over 5 million people: multivitamins may support memory and lower systolic blood pressure in some older or at-risk groups, but offer little for healthy adults. She also reports lab audits of Nicotinamide Mononucleotide (NMN) and urolithin A, in which many products fell short of the label claims.
She then sorts buzzworthy compounds like alpha-ketoglutarate, spermidine, curcumin, and melatonin by mechanism, trial quality, and fit. Her rule stays simple: measure what you can, match the dose to the need, and track outcomes with walking speed, grip strength, steps, and wearable sleep data over time, not once.
Guest-at-a-Glance
💡 Name: Dr. Andrea Maier
💡 What she does: Professor in Medicine, Healthy Ageing and Dementia Research, and Director of the NUS Academy for Healthy Longevity
💡 Company: the National University of Singapore’s School of Medicine
💡 Noteworthy: She runs human trials on supplements and aging, audits label accuracy in the lab, and pushes a “measure first” approach using biomarkers, wearables, and simple strength tests.
💡 Where to find her: https://www.linkedin.com/in/andreamaierprof
💡 Guest Company Website: https://discovery.nus.edu.sg/19564-andrea-britta-maier
Episode highlights:
[00:01:02]: Overview of Evidence-Based Clinical Practice
[00:02:16]: Multivitamins and Minerals: Usage and Population Trends
[00:04:08]: Systematic Review Findings on Multivitamins and Cognitive Health
[00:05:44]: Who Benefits Most from Multivitamin Supplementation
[00:06:57]: Personalized Nutrition and the Case for Targeted Supplementation
[00:08:21]: Ongoing Clinical Trials on Multivitamins and Biological Age
[00:09:19]: Supplement Quality: Label Claims Versus Actual Content
[00:12:14]: Navigating Supplement Quality and Consumer Guidance
[00:14:53]: Novel Longevity Compounds: Alpha-Ketoglutarate
[00:17:47]: Alpha-Ketoglutarate: Human Evidence and Population Focus
[00:18:29]: Spermidine: Dietary Sources and Human Evidence
[00:21:25]: Curcumin: Mechanisms, Evidence, and Target Populations
[00:24:54]: Evaluating Supplements for Clinical Use
[00:27:08]: Scientific Approach to Supplement Research
[00:29:26]: The Role of Independent Research in Supplement Evaluation
[00:32:37]: Melatonin: Sleep, Jet Lag, and Circadian Rhythm
[00:37:25]: Practical Melatonin Use for Travel and Sleep Optimization
[00:41:05]: Digital Biomarkers: Definition and Emerging Role
[00:45:54]: Integrating Digital Biomarkers into Healthcare Practice
[00:49:05]: Physical Function Tests: Grip Strength and Sit-to-Stand
[00:59:48]: NAD Precursors: NMN, NR, and Human Trials
[01:05:23]: NAD Testing: Current Landscape and Future Directions
[01:07:24]: Final Takeaways and Closing Remarks
For science-backed ways to live a healthier, longer life, download InsideTracker's Top 5 biomarkers for longevity eBook at insidetracker.com/podcast
Comments
Want to join the conversation?
Loading comments...